Key points• Neural-mediated relaxation occurs in the gastrointestinal tract. To accomplish this function, two neurotransmitters, ATP or a related purine and nitric oxide, are released by inhibitory motorneurons.• The type of purinergic receptor is still under debate but previous data using a classical pharmacological approach (receptor agonists and antagonists) suggested that P2Y 1 receptors are responsible for purinergic neurotransmission in the gastrointestinal tract.• In the present study we used a genetically modified mouse in which P2Y 1 receptors had been knocked out.• P2Y 1 -deficient mice had functional nitrergic neurotransmission but purinergic neurotransmission was absent.• The present work confirms the hypothesis demonstrating that P2Y 1 receptors mediate the purinergic component of the smooth muscle relaxation in the gastrointestinal tract.Abstract Purinergic and nitrergic co-transmission is the dominant mechanism responsible for neural-mediated smooth muscle relaxation in the gastrointestinal tract. The aim of the present paper was to test whether or not P2Y 1 receptors are involved in purinergic neurotransmission using P2Y 1 −/− knock-out mice. Tension and microelectrode recordings were performed on colonic strips. In wild type (WT) animals, electrical field stimulation (EFS) caused an inhibitory junction potential (IJP) that consisted of a fast IJP (MRS2500 sensitive, 1 μM) followed by a sustained IJP (N ω -nitro-L-arginine (L-NNA) sensitive, 1 mM). The fast component of the IJP was absent in P2Y 1 −/− mice whereas the sustained IJP (L-NNA sensitive) was recorded. In WT animals, EFS-induced inhibition of spontaneous motility was blocked by the consecutive addition of L-NNA and MRS2500. In P2Y 1 −/− mice, EFS responses were completely blocked by L-NNA. In WT and P2Y 1 −/− animals, L-NNA induced a smooth muscle depolarization but 'spontaneous' IJP (MRS2500 sensitive) could be recorded in WT but not in P2Y 1 −/− animals. Finally, in WT animals, 1 μM MRS2365 caused a smooth muscle hyperpolarization that was blocked by 1 μM MRS2500. In contrast, 1 μM MRS2365 did not modify smooth muscle resting membrane potential in P2Y 1 −/− mice. β-Nicotinamide adenine dinucleotide (β-NAD, 1 mM) partially mimicked the effect of MRS2365. We conclude that P2Y 1 receptors mediate purinergic neurotransmission in the gastrointestinal tract and β-NAD partially fulfils the criteria to participate in rodent purinergic neurotransmission. The P2Y 1 −/− mouse is a useful animal model to study the selective loss of purinergic neurotransmission.